Last reviewed · How we verify
Belinostat IV
At a glance
| Generic name | Belinostat IV |
|---|---|
| Also known as | Beleodaq |
| Sponsor | Acrotech Biopharma Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Belinostat IV CI brief — competitive landscape report
- Belinostat IV updates RSS · CI watch RSS
- Acrotech Biopharma Inc. portfolio CI